Fifth Third Raises Q2 Dividend by 8.3% – Analyst Blog
Fifth Third Bancorp ( FITB ) has announced a cash dividend of 13 cents per common share for second quarter …read more
Investing and Market Analysis
Ford Europe Sales Fall in May, Up YoY – Analyst Blog
Ford Motor Co. ( F ) reported a 0.9% dip in May sales in Europe to 98,600 units. The automaker …read more
Merck KGaA-Ono Pharma Deal Ends – Analyst Blog
Merck KGaA ( MKGAF ) has decided to terminate its license agreement with Ono Pharmaceutical Co., Ltd. ( OPHLF ) …read more
Will Amazon’s (AMZN) New Fire Phone Offer Enough Features To Make Consumers Switch? – Video Blog
Watch Tracey Ryniec in a flash update discuss the pros and cons of the New Fire Phone from Amazon (AMZN). …read more
J&J’s Velcade in Focus at the European Hematology Association – Analyst Blog
Johnson & Johnson ( JNJ ) presented encouraging data from a phase III study on its oncology drug, Velcade, at …read more
Lumber Liquidators Down to Strong Sell – Analyst Blog
On Jun 17, 2014, Zacks Investment Research downgraded Lumber Liquidators Holdings, Inc. ( LL ) to a Zacks Rank #5 …read more
SanDisk Offers $1.1B to Acquire Fusion-io – Analyst Blog
Flash memory storage provider SanDisk Corp. ( SNDK ) recently inked a deal to acquire Fusion io Inc. ( FIO …read more
Glaxo’s Promacta Holds Promise – Analyst Blog
Updates related to pipeline and label expansion efforts are eagerly awaited by investors in the biotech pharma space as these …read more
Novartis Submits Bexsero to FDA for Marketing Approval – Analyst Blog
Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more
Vertex Pharmaceuticals Crumbles on Analyst Worries – Analyst Blog
Bernstein analyst Geoff Porges has concluded that two pivotal phase III studies (TRAFFIC and TRANSPORT) on Vertex Pharmaceuticals Incorporated ‘s …read more